MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have ...

Letters of support for Binance co-founder CZ have poured into a Washington court requesting leniency in his sentencing tomorrow. Zhao's lawyers have requested their client be sentenced to ...

The US Food and Drug Administration (FDA) yesterday issued a Complete Response Letter (CRL) regarding US drug developer Galera Therapeutics (Nasdaq: GRTX) New Drug Application (NDA) for avasopasem ...

Galera Therapeutics, Inc. announced that its Board of Directors has unanimously resolved to adopt a limited duration stockholder rights agreement to protect stockholder interests. Galera Therapeutics, ...